Schamroth L, Krikler D M, Garrett C
Br Med J. 1972 Mar 11;1(5801):660-2. doi: 10.1136/bmj.1.5801.660.
Verapamil was administered by intravenous injection to 181 patients with various cardiac arrhythmias. The automaticity of the cardiac pacemaker was slowed in sinus, idionodal, and idioventricular tachycardia. In atrial fibrillation the drug usually slowed the ventricular response and often made it regular. In some cases atrial flutter was converted to sinus rhythm, the ventricular response being reduced in the remainder. Conversion of paroxysmal supraventricular tachycardia to sinus rhythm was consistently achieved. A favourable response occurred in four patients in whom arrhythmias were associated with pre-excitation syndromes. There were no adverse clinical side effects.
对181例各种心律失常患者进行了维拉帕米静脉注射。在窦性、结性和室性心动过速中,心脏起搏器的自律性减慢。在心房颤动中,该药通常会减慢心室反应并常常使其规律化。在某些情况下,心房扑动可转变为窦性心律,其余患者的心室反应则降低。阵发性室上性心动过速持续转变为窦性心律。4例心律失常与预激综合征相关的患者出现了良好反应。未出现不良临床副作用。